Zimmer Biomet Holdings, Inc.ZBHNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +4.28% | +1.05% | +6.97% | +9.71% | +10.90% |
| Gross Profit Growth | +2.51% | -1.28% | +6.96% | +12.17% | +1.04% |
| EBITDA Growth | +6.68% | +8.96% | -3.49% | +19.18% | -26.14% |
| Operating Income Growth | +9.82% | +9.93% | -14.60% | +25.69% | -26.02% |
| Net Income Growth | -42.87% | +5.57% | -37.07% | -7.31% | -41.75% |
| EPS Growth | -40.30% | +9.52% | -34.75% | -4.88% | -40.83% |
| EPS Diluted Growth | -40.30% | +8.33% | -34.75% | -5.69% | -41.67% |
| Weighted Average Shares Growth | -4.23% | -3.07% | -3.79% | -2.08% | -0.95% |
| Weighted Average Shares Diluted Growth | -4.17% | -3.15% | -3.92% | -2.07% | -0.90% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -13.95% | +67.89% | +2.38% | +5.81% | +2.17% |
| Free Cash Flow Growth | -19.82% | +159.10% | +33.68% | +48.07% | +58.69% |
| Receivables Growth | +2.66% | +6.01% | +13.63% | +7.88% | +15.11% |
| Inventory Growth | -6.28% | -6.03% | +3.56% | +4.85% | +2.29% |
| Asset Growth | -0.61% | +3.41% | +6.25% | +8.14% | +8.08% |
| Book Value per Share Growth | +4.32% | +1.51% | +2.18% | +5.27% | +2.89% |
| Debt Growth | +7.57% | +23.81% | +29.78% | +25.76% | +21.19% |
| R&D Expense Growth | -4.24% | +2.50% | +3.56% | +3.85% | +9.49% |
| SG&A Expenses Growth | +3.41% | +3.07% | +10.54% | +14.33% | +16.09% |